Community prescribing and resistant Streptococcus pneumoniae

Emerging Infectious Diseases

Volumn 11, Issue 6, 2005, Pages 829-837

  Barkai, Galia ^a   Greenberg, David ^a   Givon Lavi, Noga ^a   Dreifuss, Eli ^b   Vardy, Daniel ^b   Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b Israel General Health Insurance Plan   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFALEXIN; CEFUROXIME AXETIL; ERYTHROMYCIN ETHYLSUCCINATE; ERYTHROMYCIN STEARATE; PENICILLIN V; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MIDDLE EAR; MULTIDRUG RESISTANCE; MYRINGOTOMY; OTITIS MEDIA; PRESCRIPTION; STREPTOCOCCUS PNEUMONIAE;

EID: 19344362311     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1106.050198     Document Type: Article

References (40)

1. Nyquist A, Gonzales R, Steiner J, Sande M. Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA. 1998;279:875-7.
2. Granizo JJ, Aguilar L, Casal J, Garcia-Rey C, Dal-Re R, Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother. 2000;46:767-73.
3. Cizman M, Pokorn M, Seme K, Orazem A, Paragi M. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J Antimicrob Chemother. 2001;47:475-7.
4. Melander E, Ekdahl K, Jonsson G, Molstad S. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr Infect Dis J. 2000;19:1172-7.
5. Diekema DJ, Brueggemann AB, Doern GV. Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae. Emerg Infect Dis. 2000;6:552-6.
6. Harbarth S, Albrich W, Brun-Buisson C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis. 2002;8:1460-7.
7. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Martin JE. Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol. 2002;40:2959-63.
8. Reinen RR, AJ-Lahham A, Lemperle M, Tenholte C, Briefs C, Haupts S, et al. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother. 2002;49:61-8.
9. Teele DW, Klein JO, Rosner B, Bratton L, Fisch GR, Mathieu OR, et al. Middle ear disease and the practice of pediatrics. Burden during the first five years of life. JAMA. 1983;249:1026-9.
10. del Beccaro MA, Mendelman PM, Inglis AF, Richardson MA, Duncan NO, Clausen CR, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992;120:81-4.
11. Baquero F, Loza E. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr Infect Dis J. 1994;13(Suppl 1):S9-S14; discussion S20-S2.
12. Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42:589-95.
13. Klein JO. Clinical implications of antibiotic resistance for management of acute otitis media. Pediatr Infect Dis J. 1998;17:1084-9; 1099-1100.
14. Dagan R. Treatment of acute otitis media -challenges in the era of antibiotic resistance. Vaccine. 2000;19 (Suppl 1):S9-S16.
15. Central Bureau of Statistics. Statistical Abstracts of Israel, 1998. No. 49. Jerusalem: Hemed Press Ltd; 1998.
16. Dagan R, Landau D, Haikin H, Tal A. Hospitalization of Jewish and Bedouin infants in southern Israel for bronchiolitis caused by respiratory syncytial virus. Pediatr Infect Dis J. 1993;12:381-6.
17. Levy A, Fraser D, Vardi H, Dagan R. Hospitalizations for infectious diseases in Jewish and Bedouin children in southern Israel. Eur J Epidemiol. 1998;14:179-86.
18. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med. 1976;43:699-709.
19. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: 12th informational supplement. Wayne (PA): NCCLS, 2002; Document M100-S12, Vol. 22, No. 1.
20. Jacobs MR, Bajaksouzian S, Appelbaum PC, Bolmstrom A. Evaluation of the E-test for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis. 1992;15:473-8.
21. Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, et al. Reduction in antibiotic use among US children, 1996-2000. Pediatrics. 2003;112:620-7.
22. Stille CJ, Andrade SE, Huang SS, Nordin J, Raebel MA, Go AS, et al. Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics. 2004;114:1206-11.
23. Patrick DM, Marra F, Hutchinson J, Monnet DL, Ng H, Bowie WR. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? Clin Infect Dis. 2004;39:11-7.
24. Nightingale CH. Pharmacokinetics and pharmacodynamics of newer macrolides. Pediatr Infect Dis J. 1997;16:438-43.
25. Guggenbichler JP, Kastner U. Development of resistance in vitro by subinhitory concentrations of macrolide antibiotics. In: Program and abstracts of the 4th International Conference on the Macrolides, Azalides, Streptogramins and Ketolides; Barcelona, Spain; 1998. p. 3.11.
26. Kastner U, Guggenbichler JP. Influence of macrolide antibiotics on promotion of resistance in the oral flora of children. Infection. 2001;29:251-6.
27. Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis. 2004;10:514-7.
28. Dias R, Canica M. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. J Antimicrob Chemother. 2004;54:1035-9.
29. Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8:278-82.
30. Garcia-Rey C, Aguilar L, Baquero F, Casal J, Dal-Re R. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J Clin Microbiol. 2002;40:159-64.
31. McCormick AW, Whitney CG, Farley MM, Lynfield R, Harrison LH, Bennett NM, et al. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nat Med. 2003;9:424-30.
32. Dagan R, Greenberg D, Leiberman A, Peled N, Leibovitz E. S. pneumoniae carriage in children with acute otitis media treated with high dose amoxicillin/clavulanate or axithromycin in the presence of high prevalence of antibiotic resistance. In: 43rd International Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. Sep 14-17, 2003. Washington: American Society for Microbiology; 2003; Abstract G-1856.
33. Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics. 2004;113:443-9.
34. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-46.
35. Block SL, Hedrick J, Harrison CJ, Tyler R, Smith A, Findlay R, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23:829-33.
36. Pelton SI. Modifying acute otitis media: implications of immunization with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2004;23:839-41.
37. Pletz MW, McGee L, Jorgensen J, Beall B, Facklam RR, Whitney CG, et al. Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine. Antimicrob Agents Chemother. 2004;48:3491-7.
38. Moore MR, Hyde TB, Hennessy TW, Parks DJ, Reasonover AL, Harker-Jones M, et al. Impact of a conjugate vaccine on community-wide carriage of nonsusceptible Streptococcus pneumoniae in Alaska. J Infect Dis. 2004;190:2031-8.
39. Porat N, Barkai G, Jacobs MR, Trefler R, Dagan R. Four antibiotic resistant S. pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern Israel. J Infect Dis. 2004;189:385-92.
40. Pelton SI, Loughlin AM, Marchant CD. Seven valent pneumococcal conjugate vaccine immunization in 2 Boston communities: changes in serotypes and antimicrobial susceptibility among Streptococcus pneumoniae isolates. Pediatr Infect Dis J. 2004;23:1015-22.